As of 2025-10-18, the Relative Valuation of Intellipharmaceutics International Inc (IPCI.TO) is (0.05) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 CAD, the upside of Intellipharmaceutics International Inc based on Relative Valuation is -165.1%.
The range of the Relative Valuation is (0.02) - (0.08) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.2x - 0.7x | 0.4x |
| Forward P/E multiples | 0.2x - 0.7x | 0.4x |
| Fair Price | (0.02) - (0.08) | (0.05) |
| Upside | -126.0% - -204.1% | -165.1% |
| Date | P/E |